Our results indicated that H2S reduced the levels of TNF-α, IL-1β, and IL-6 in the liver of HFD-fed mice, suggesting that H2S may relieve NAFLD partly by decreasing inflammation in the liver. Here, IL1B is linked to metabolic dysfunction-associated steatotic liver disease.